New Applications of Hermetic Storage for Grain Storage and Transport

Recent evolution of pesticide-free post harvest hermetic storage for dry commodities as now used in 38 countries is described, and its current application in the storage of grain and other commodities is discussed and illustrated. Results of studies carried out on the protection of seeds, rice, maize, wheat, pulses, cocoa and coffee are presented. Plastic structures suitable for long-term storage systems have been developed and applied. The growing number of types of flexible hermetic containers for various needs, especially in tropical conditions, is documented. Types of hermetic containers include: 1) Portable containers of 60-kg to 2-tonne, called SuperGrainbagsTM which are suitable for seed storage in bulk; 2) Bulk storage for household or farm use and daily withdrawal of grain of   1-tonne called Grainsafe IITM; 3) Flexible enclosures of 5- to 1000-tonne capacity termed storage cubes or CocoonsTM, designed for storage at the farmer-cooperative and small trader level or larger commercial and strategic storage facilities; 4) Hermetic Bunker storage for longterm storage in bulk of 10,000- to 20,000-tonnes; 5) TranSafelinerTM provide quality preservation, insect control, and prevention of condensation during shipment of bagged commodities in containers across intercontinental distances. Recent applications for wheat storage in bunkers in Jordan, and cocoa storage in West Africa, and the growing use of hermetic liners for intercontinental shipments of a variety of commodities, are described. Key performance parameters for safe storage in the face of elevated humidity and temperature in preventing growth of molds and the survival of insects for dry and wet commodities are discussed. Economic analysis is provided for representative applications, including rice, maize and cocoa. Keywords: Hermetic storage, Modified atmospheres, Quality preservation, Storage insect control, Flexible storage structure

Hermetic storage: A novel approach to the protection of cocoa beans

Hermetic storage has provided a successful storage method for protection of commodities without fumigants or need for refrigeration for insect control and quality preservation of stored products. Hermetic storage is achieved in specially constructed plastic structures for the preservation of cereal grains and other commodities. Plastic structures suitable for long-term storage systems, as well as intermediate storage of grain have been developed and applied. These storage systems based on the hermetic principle were designed for (1) storage at the farmercooperativeand small trader level with 10 - 1000 tonnes capacity for enclosing stacks termed Cocoons™, (2) small scale storage suitable for small portable containers of 60 kg to 2 tonnes called SuperGrainbags™ and (3)quality preservation, insect control and prevention of condensation during shipment of commodities in shipping containers known as  ranSafeliners™. Hermetic storage is based on the principle of generation of an oxygendepleted, carbon dioxide-enriched interstitial atmosphere caused by the respiration of the living organisms in the ecological system of a sealed storage. A sufficiently low oxygen and elevated CO2, atmosphere is created through a natural metabolic process based on insect respiration and, in cases where the commodity has sufficiently high moisture, the respiration of the microorganisms within a sealed storage system. Applications for which hermetic technology has been most widely accepted are long-term storage of cereal grains, primarily rice, corn, barley,wheat and a variety of seeds to preserve germination potential and vigor and quality preservation of high-value commodities such as cocoa and coffee. Under field conditions in a cocoa bean storage facility in Makassar,Indonesia, a hermetically sealed flexible structure containing 6.7 tonnes of cocoa beans at an initial moisture content of 7.3% and relative humidity of 70% was monitored for oxygen concentration and quality parameters ofthe beans. The measurements showed a decrease in oxygen concentration to 0.3% after 5.5 days. No insects survived the oxygen depleted biogenerated atmosphere. Similar trials were carried out in Ghana by COCOBOD in which three stacks for hermetic storage and one stack each for conventional storage (without fumigation) and standard storage (with fumigation) were built for sampling and observation. At the sixth week of storage 100% mortality of insects was recorded in the CocoonTM. All the cocoa beans inside the CocoonTM maintained their quality category throughout the storage period and the grade remained the same after nine weeks of storage as it was at the beginning of the experiment

Primary beam effects of radio astronomy antennas -- II. Modelling the MeerKAT L-band beam

After a decade of design and construction, South Africa's SKA-MID precursor MeerKAT has begun its science operations. To make full use of the widefield capability of the array, it is imperative that we have an accurate model of the primary beam of its antennas. We have taken available L-band full-polarization 'astro-holographic' observations of three antennas and a generic electromagnetic simulation and created sparse representations of the beams using principal components and Zernike polynomials. The spectral behaviour of the spatial coefficients has been modelled using discrete cosine transform. We have provided the Zernike-based model over a diameter of 10 deg averaged over the beams of three antennas in an associated software tool (EIDOS) that can be useful in direction-dependent calibration and imaging. The model is more accurate for the diagonal elements of the beam Jones matrix and at lower frequencies. As we get more accurate beam measurements and simulations in the future, especially for the cross-polarization patterns, our pipeline can be used to create more accurate sparse representations of MeerKAT beams.Comment: 16 pages, 18 figures. This is a pre-copyedited, author-produced PDF of an article accepted for publication in MNRAS following peer review. The version of record [K. M. B. Asad et al., 2021] is available online at: https://doi.org/10.1093/mnras/stab10

A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of clinically significant prostate cancer in men without prior biopsy: a study protocol

INTRODUCTION: The classical pathway for the diagnosis of prostate cancer is transrectal ultrasound-guided (TRUS) biopsy of the prostate initiated on the basis of a raised prostate-specific antigen (PSA). An alternative pathway is to perform multi-parametricMRI (MPMRI) to localise cancer and to use this information to influence the decision for, and conduct of, a subsequent biopsy, known as an MPMRI-targeted biopsy. An MPMRI pathway has been shown to detect a similar or greater amount of clinically significant cancer as TRUS biopsy but has several advantages, including the potential to biopsy fewer men with fewer cores. METHODS: This is a pragmatic, international, multicentre, parallel group randomised study in which men are allocated in a 1:1 ratio to an MPMRI or TRUS biopsy pathway. This study will assess whether an MPMRI-targeted biopsy approach is non-inferior to a standard TRUS biopsy approach in the diagnosis of clinically significant cancer.Men in the MRI arm will undergo targeted biopsy of suspicious areas only and no biopsy will be carried out if the MRI is non-suspicious. Men in the TRUS biopsy will undergo a standard 10-12-core TRUS biopsy. The main inclusion criteria are a serum PSA ≤20 ng/mL, a digital rectal examination finding of T2 or less and no prior prostate biopsy.The primary outcome is the proportion of men with clinically significant cancer detected. A sample size of at least 470 patients is required. Key secondary outcomes include the proportion of clinically insignificant cancer detected. ETHICS AND DISSEMINATION: Ethical approval was obtained from the National Research Ethics Committee East Midlands, Leicester (15/EM/0188). Results of this study will be disseminated through national and international papers. The participants and relevant patient support groups will be informed about the results of the study. REGISTRATION DETAILS: NCT02380027; Pre-results

Natural Variability and Warming Signals in Global Ocean Wave Climates

地球全体の波浪特性の変化傾向と自然変動の関係を解明 --地球温暖化の沿岸域への影響を定量化--. 京都大学プレスリリース. 2021-06-15.This paper presents a multivariate classification of the global wave climate into types driven by atmospheric circulation patterns. The primary source of the net long-term variability is evaluated based on historical wave simulations. Results show that the monsoon, extratropical, subtropical, and polar wave climate types of the Pacific and North Atlantic Oceans are dominated by natural variability, whereas the extratropical and subtropical wave climate types in the Indian Ocean, and the tropical wave climate types of the Atlantic and Pacific Oceans exhibit a global warming signal. In the Pacific sector of the Southern Ocean, strong natural variability may mask a global warming signal that is yet to emerge as being statistically significant. In addition, wave climate teleconnections were found across the world that can provide a framework for joint strategies to achieve the goals of climate adaption for resilient coastal communities and environments

Energiförbrukning och potentiell energibesparing vid badanläggningar : förstudie /

1. The relative contributions of habitat and food availability on fitness may provide evidence for key habitat features needed to safeguard population persistence. However, defining habitat quality for a species can be a complex task, especially if knowledge on the relationship between individual performance and habitat quality is lacking. 2. Here, we determined the relative importance of availability of suitable forest habitat, body mass, and food from masting tree species on female lifetime reproductive success (LRS) of Siberian flying squirrels (Pteromys volans). 3. We calculated LRS of 500 female flying squirrels based on a 22 year-long longitudinal data set of two populations from western Finland. We assessed with generalised additive models the potential effects of availability of suitable habitat and cumulative lifetime availability of food from masting tree species on female LRS, longevity and fecundity. On a reduced dataset, we evaluated the importance of female winter body mass and conducted a piecewise path analysis to determine how variables were connected. 4. According to generalised additive models female longevity, fecundity and LRS were mainly determined by variation in cumulative lifetime availability of food from masting alder and birch. Instead, habitat and body mass had smaller role. The path analysis indicated that lifetime food availability had direct effect on longevity and fecundity, and these had equal effect on LRS at both study sites. 5. Our results on LRS shows that the occurrence of tree masting events during a flying squirrel female’s lifetime have profoundly larger effect on lifetime reproductive success than the cover of suitable forest habitat. Furthermore, this study emphasises the importance of both fecundity and longevity, and the indirect effects of food availability via those components, as determinants of lifetime fitness of female flying squirrels

TOOKAD® Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer

Purpose: To evaluate the 6-month effects of the recommended drug and light dosage in focal vascular-targeted photodynamic therapy (VTP) using TOOKAD® Soluble in patients with localized prostate cancer (LPCa). Methods: We performed a pooled analysis of 117 men with LPCa, PSA <10 ng/mL, and Gleason score ≤7 (3 + 4), from 3 studies who received a 10-min intravenous infusion of a single dose of 4 mg/kg TOOKAD® Soluble, activated by a 753-nm light at 200 J/cm delivered in the prostate by transperineal fibres under transrectal ultrasound guidance. Primary endpoint was 6-month negative biopsies in the treated lobe(s). PSA was measured at month 1, 3, and 6. Magnetic resonance imaging was performed at day 7, month 3, and 6. International Prostate Symptom Score (IPSS), International Index of Erectile Function (IIEF-5) and adverse events were reported at day 7, month 1, 3, and 6. Results: Month 6 negative biopsy rate was 68.4 % in the overall evaluable population (N = 114) and 80.6 % for patients treated by hemiablation with light density index (LDI) ≥ 1 (N = 67). Mean prostate necroses at week-1 were 76.5 and 86.3 %, respectively. In both groups, PSA levels at month 6 decreased by 2.0 ng/mL. Small changes from baseline for IPSS and IIEF-5 indicated a slight improvement in urinary function and a slight deterioration in sexual function. Conclusions: Focal VTP treatment with TOOKAD® Soluble at 4 mg/kg and 200 J/cm resulted in a negative 6-month biopsy rate of 68.4 % for the whole population and 80.6 % for patients treated by hemiablation with LDI ≥ 1. The treatment was well tolerated. Two phase III studies will reach completion in early 2015

Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapy

Objective: To determine the optimal drug and light dose for prostate ablation using WST11 (TOOKAD® Soluble) for vascular-targeted photodynamic (VTP) therapy in men with low-risk prostate cancer. Patients and Methods: In all, 42 men with low-risk prostate cancer were enrolled in the study but two who underwent anaesthesia for the procedure did not receive the drug or light dose. Thus, 40 men received a single dose of 2, 4 or 6 mg/kg WST11 activated by 200 J/cm light at 753 nm. WST11 was given as a 10-min intravenous infusion. The light dose was delivered using cylindrical diffusing fibres within hollow plastic needles positioned in the prostate using transrectal ultrasonography (TRUS) guidance and a brachytherapy template. Magnetic resonance imaging (MRI) was used to assess treatment effect at 7 days, with assessment of urinary function (International Prostate Symptom Score [IPSS]), sexual function (International Index of Erectile Function [IIEF]) and adverse events at 7 days, 1, 3 and 6 months after VTP. TRUS-guided biopsies were taken at 6 months. Results: In all, 39 of the 40 treated men completed the follow-up. The Day-7 MRI showed maximal treatment effect (95% of the planned treatment volume) in men who had a WST11 dose of 4 mg/kg, light dose of 200 J/cm and light density index (LDI) of >1. In the 12 men treated with these parameters, the negative biopsy rate was 10/12 (83%) at 6 months, compared with 10/26 (45%) for the men who had either a different drug dose (10 men) or an LDI of <1 (16). Transient urinary symptoms were seen in most of the men, with no significant difference in IPSS score between baseline and 6 months after VTP. IIEF scores were not significantly different between baseline and 6 months after VTP. Conclusion: Treatment with 4 mg/kg TOOKAD Soluble activated by 753 nm light at a dose of 200 J/cm and an LDI of >1 resulted in treatment effect in 95% of the planned treatment volume and a negative biopsy rate at 6 months of 10/12 men (83%)

MRI-targeted or standard biopsy for prostate-cancer diagnosis

Background Multiparametric magnetic resonance imaging (MRI), with or without targeted biopsy, is an alternative to standard transrectal ultrasonography-guided biopsy for prostate-cancer detection in men with a raised prostate-specific antigen level who have not undergone biopsy. However, comparative evidence is limited. Methods In a multicenter, randomized, noninferiority trial, we assigned men with a clinical suspicion of prostate cancer who had not undergone biopsy previously to undergo MRI, with or without targeted biopsy, or standard transrectal ultrasonography-guided biopsy. Men in the MRI-targeted biopsy group underwent a targeted biopsy (without standard biopsy cores) if the MRI was suggestive of prostate cancer; men whose MRI results were not suggestive of prostate cancer were not offered biopsy. Standard biopsy was a 10-to-12-core, transrectal ultrasonography-guided biopsy. The primary outcome was the proportion of men who received a diagnosis of clinically significant cancer. Secondary outcomes included the proportion of men who received a diagnosis of clinically insignificant cancer. Results A total of 500 men underwent randomization. In the MRI-targeted biopsy group, 71 of 252 men (28%) had MRI results that were not suggestive of prostate cancer, so they did not undergo biopsy. Clinically significant cancer was detected in 95 men (38%) in the MRI-targeted biopsy group, as compared with 64 of 248 (26%) in the standard-biopsy group (adjusted difference, 12 percentage points; 95% confidence interval [CI], 4 to 20; P=0.005). MRI, with or without targeted biopsy, was noninferior to standard biopsy, and the 95% confidence interval indicated the superiority of this strategy over standard biopsy. Fewer men in the MRI-targeted biopsy group than in the standard-biopsy group received a diagnosis of clinically insignificant cancer (adjusted difference, -13 percentage points; 95% CI, -19 to -7; P&lt;0.001). Conclusions The use of risk assessment with MRI before biopsy and MRI-targeted biopsy was superior to standard transrectal ultrasonography-guided biopsy in men at clinical risk for prostate cancer who had not undergone biopsy previously. (Funded by the National Institute for Health Research and the European Association of Urology Research Foundation; PRECISION ClinicalTrials.gov number, NCT02380027 .)